LillyDirect (Zepbound) vs. ShedRx: prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, ShedRx is the cheaper program at $289 a month all-in versus LillyDirect (Zepbound)'s $449 — a gap of $160 a month, $1,920 a year, at the 10 mg maintenance basis. LillyDirect (Zepbound): $449 a month all-in at the 10 mg maintenance basis, dose-scaled from a $299 entry, no membership fee. ShedRx: $289 a month all-in at the 10 mg maintenance basis, dose-scaled from a $199 entry, no membership fee.

Semaglutide pricing

Only ShedRx publishes a semaglutide price here: Semaglutide runs $249 a month all-in at the standing rate ($175 on intro/plan terms). LillyDirect (Zepbound) doesn't sell compounded semaglutide — its lane is brand fulfillment.

Different products, not just different prices

LillyDirect (Zepbound) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while ShedRx sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

LillyDirect (Zepbound): Source-verified (verified 2026-08-09); names its pharmacy — Eli Lilly direct / retail partners. ShedRx: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

LillyDirect (Zepbound): 45-day refill cadence to keep pricing; no subscription; refill-window rules apply. ShedRx: none month-to-month; 72-hour notice before the next billing cycle.

The gap, compounded over time

Here is what the $160 monthly spread between these two actually buys back over a treatment course — one month, $160; six months, $960; a year, $1,920; two years of maintenance, $3,840. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Maintenance therapies deserve maintenance math: over two years at standing rates, LillyDirect (Zepbound) bills $10,776 and ShedRx $6,936, a spread of $3,840 for the same molecule at the same 10 mg basis. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

Put both dose ladders on the same axis and the structures argue for themselves: LillyDirect (Zepbound) steps $299 → $399 → $449 and holds $449 from 7.5 mg up (four-month titration: $1,596); ShedRx scales $199 → ~$289 by 10 mg (titration lands between $796 and $1,156). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $299 at LillyDirect (Zepbound) versus $199 at ShedRx for the 2.5 mg rung — an early edge that holds once the ladder climbs. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,468/year at ShedRx against $5,388 at the other: $1,920 of annual daylight for the same molecule and dose.

The semaglutide board

Only ShedRx fields a verified semaglutide price here — $249/month all-in (#13 of 19) — while LillyDirect (Zepbound) focuses its published pricing on tirzepatide. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. LillyDirect (Zepbound)'s ranked figure is $449, with no membership to add; ShedRx's ranked figure is $289, with no membership to add. 2 · Maintenance basis. LillyDirect (Zepbound) scales from $299 to $449, and the 10 mg figure is the one ranked; ShedRx scales from $199 to $289, and the 10 mg figure is the one ranked. 3 · Terms separated. LillyDirect (Zepbound): standing $449, no prepaid tier; ShedRx: standing $289, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. LillyDirect (Zepbound): source-verified, read 2026-08-09; ShedRx: source-verified, read 2026-08-05. 5 · Pharmacy weighed. LillyDirect (Zepbound) names Eli Lilly direct / retail partners; ShedRx names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

LillyDirect (Zepbound): no membership — the medication figure is the billed figure; no subscription; refill-window rules apply; commitment: 45-day refill cadence to keep pricing. ShedRx: no membership — the medication figure is the billed figure; 72-hour notice before the next billing cycle; commitment: none month-to-month. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

LillyDirect (Zepbound) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Eli Lilly direct / retail partners, manufacturer direct. ShedRx carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from LillyDirect (Zepbound) to ShedRx (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: LillyDirect (Zepbound): shipping included (or same-day retail pickup); consultation bring your own prescription (telehealth partners available); prescription required visit model; a ~45-day refill cadence guards the self-pay tiers (lapse and fills reprice $599–$1,049 until re-enrollment). ShedRx: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick LillyDirect (Zepbound) if a named pharmacy is non-negotiable for you; only the FDA-approved product will do. Pick ShedRx if the $160/month tirzepatide saving is the point. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are Fridays at $359 (flat, no membership); Lavender Sky Health at $352 (dose-scaled, $25 membership included); Henry Meds at $349 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

On the numbers alone, ShedRx is the cheaper tirzepatide program by $160/mo and it doesn't trade that price for opacity ; LillyDirect (Zepbound)'s case rests on FDA-approved product, better pharmacy disclosure. Both records, with dates and sources, live in the pricing database.